Hit and go CAS9 delivered through a lentiviral based self-limiting circuit

Nature Communications
Gianluca PetrisAnna Cereseto

Abstract

In vivo application of the CRISPR-Cas9 technology is still limited by unwanted Cas9 genomic cleavages. Long-term expression of Cas9 increases the number of genomic loci non-specifically cleaved by the nuclease. Here we develop a Self-Limiting Cas9 circuit for Enhanced Safety and specificity (SLiCES) which consists of an expression unit for Streptococcus pyogenes Cas9 (SpCas9), a self-targeting sgRNA and a second sgRNA targeting a chosen genomic locus. The self-limiting circuit results in increased genome editing specificity by controlling Cas9 levels. For its in vivo utilization, we next integrate SLiCES into a lentiviral delivery system (lentiSLiCES) via circuit inhibition to achieve viral particle production. Upon delivery into target cells, the lentiSLiCES circuit switches on to edit the intended genomic locus while simultaneously stepping up its own neutralization through SpCas9 inactivation. By preserving target cells from residual nuclease activity, our hit and go system increases safety margins for genome editing.

References

Jun 1, 1997·Protein Engineering·E LiO Burrone
Jun 10, 2009·Bioinformatics·Heng LiUNKNOWN 1000 Genome Project Data Processing Subgroup
Jan 19, 2010·Bioinformatics·Heng Li, Richard Durbin
Apr 24, 2012·The Journal of Biological Chemistry·Lara VecchiOscar R Burrone
Jan 5, 2013·Science·Le CongFeng Zhang
Jan 5, 2013·Science·Prashant MaliGeorge M Church
Feb 7, 2013·ELife·Martin JinekJennifer Doudna
Jun 25, 2013·Nature Biotechnology·Yanfang FuJeffry D Sander
Jul 23, 2013·Nature Biotechnology·Patrick D HsuFeng Zhang
Oct 1, 2013·Nature Methods·Kevin M EsveltGeorge M Church
Dec 18, 2013·Science·Ophir ShalemFeng Zhang
Mar 4, 2014·Nature Biotechnology·Jeffry D Sander, J Keith Joung
May 7, 2014·AIDS Research and Human Retroviruses·Ashwanth Christopher FrancisAnna Cereseto
May 8, 2014·PloS One·Gianluca PetrisOscar R Burrone
Jul 31, 2014·Nature Methods·Neville E SanjanaFeng Zhang
Oct 11, 2014·Nucleic Acids Research·Eva K BrinkmanBas van Steensel
Nov 16, 2014·Methods in Enzymology·Vikram PattanayakDavid R Liu
Dec 17, 2014·Nature Biotechnology·Richard L FrockFrederick W Alt
Dec 17, 2014·Nature Biotechnology·Shengdar Q TsaiJ Keith Joung
Dec 21, 2014·Nucleic Acids Research·Richard MooreLeonidas Bleris
Feb 3, 2015·Nature Biotechnology·Bernd ZetscheFeng Zhang
Feb 6, 2015·Nature Medicine·David Benjamin Turitz CoxFeng Zhang
Feb 26, 2015·Proceedings of the National Academy of Sciences of the United States of America·Addison V WrightJennifer A Doudna
Apr 2, 2015·Nature·F Ann RanFeng Zhang
Apr 8, 2015·Nature Chemical Biology·Kevin M DavisDavid R Liu
Jun 13, 2015·Nature Communications·Giulia RuoziMauro Giacca
Jun 16, 2015·Nature Biotechnology·Yuta NihongakiMoritoshi Sato
Sep 8, 2015·Nature Methods·Samira KianiGeorge Church
Oct 20, 2015·Nature Methods·Mehmet Fatih BolukbasiScot A Wolfe
Dec 3, 2015·Science·Ian M SlaymakerFeng Zhang
Dec 15, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Maximilian MüllerClaudio Mussolino
Feb 10, 2016·ACS Chemical Biology·James K NuñezJennifer A Doudna

❮ Previous
Next ❯

Citations

Dec 8, 2017·Nucleic Acids Research·Daniel E RyanDouglas J Dellinger
Mar 27, 2018·The Journal of Gene Medicine·Samantha L GinnMohammad R Abedi
Apr 16, 2019·Nucleic Acids Research·Mareike D HoffmannDominik Niopek
Jan 31, 2019·Annual Review of Immunology·Dimitre R Simeonov, Alexander Marson
Feb 13, 2018·Nature Biotechnology·Antonio CasiniAnna Cereseto
Aug 8, 2019·Physiology·Courtney S YoungMelissa J Spencer
Jul 18, 2019·Immunology·Lukman O AfolabiXiaochun Wan
Nov 7, 2019·Current Genetics·Antara BarmanSupriyo Chakraborty
Jun 6, 2018·Frontiers in Cell and Developmental Biology·Camilla Højland KnudsenMark Denham
Feb 23, 2020·Science Advances·Sabine AschenbrennerDominik Niopek
Jan 9, 2019·Frontiers in Microbiology·Amanda R PanfilKristine E Yoder
Jun 20, 2018·Nature Chemical Biology·Wen Y WuJohn van der Oost
Oct 16, 2020·Gene·Ekaterina KondratevaSvetlana Smirnikhina
Oct 12, 2019·Molecular Therapy : the Journal of the American Society of Gene Therapy·Anju KelkarSriram Neelamegham
Jul 1, 2020·Advanced Drug Delivery Reviews·Wenhan Yu, Zhijian Wu
Feb 13, 2021·Gene Therapy·Dimitrios Laurin WagnerMichael Schmueck-Henneresse
Mar 16, 2021·Molecular Therapy. Methods & Clinical Development·Qian LiYang Yang
Jul 11, 2020·Molecular Therapy : the Journal of the American Society of Gene Therapy·Fan-Li LinGuei-Sheung Liu
Aug 16, 2017·ACS Chemical Biology·Jinyue PuBryan C Dickinson
Aug 21, 2021·Scientific Reports·Dashan Sun
Jun 7, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Maja van HeesKira Astakhova

❮ Previous
Next ❯

Datasets Mentioned

BETA
M12880.1
PRJNA381704

Methods Mentioned

BETA
GUIDE-seq
PCR
transfection
Assay

Software Mentioned

BWA
Cas
seq
MEM
SLiCES
GUIDE
ImageJ
lentiSLiCES
samtools
R

Related Concepts

Related Feeds

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.